Article citationsMore>>

Lai, J.H., Chang, L., Lin, S., Mo, S., Liu, H. and Qin, J. (2026) Letter to the Editor: “Incidence of Kidney Toxicity of Non-Steroidal Anti-Inflammatory Drugs in Critically Ill Patients”. Journal of Critical Care, 91, Article 155319.
https://doi.org/10.1016/j.jcrc.2025.155319

has been cited by the following article:

• TITLE: The Anticoagulant Effect of Ibuprofen and Interactions Including Anticoagulants

  AUTHORS: Dennis Flanagan

  KEYWORDS: NSAID, Hemorrhage, Pain, Dental, Coagulation, Anticoagulant

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.2, January 29, 2026

  ABSTRACT: Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug (NSAID). A clinician wishing to appropriately control more moderate to severe pain may consider a combination of orally administered ibuprofen (IBU) and acetaminophen for pain control. In dentistry, it is commonly recommended to take oral IBU 400 - 800 mg and acetaminophen 325 - 1000 mg to control postoperative pain following third molar extraction(s). This combination can avoid the use of a narcotic prescription for pain control. However, many patients are taking anticoagulants for a variety of medical conditions and are told not to take IBU, fearing an additive effect of IBU with the anticoagulant. This paper addresses the anticoagulant effects of IBU when administered as a single agent and the interactions with orally administered anticoagulant, antiplatelet, or antithrombotic agents. Ibuprofen may be taken by patients taking anticoagulants for 2 - 5 days without significant interaction. Nonetheless, the prudent clinician should ensure the patient is compliant and that alternative pain medications have been considered.